Emerging Diagnostic Modalities & Innovation
|2 min read
Researchers Analyze the Performance of GIFT, a Web-Based Cascade Testing Portal that Clinical Labs Could Use
With more than 250,000 cancer patients undergoing genetic testing this year, researchers are turning to web portals and AI to manage family notifications
|2 min read
Mayo Clinic, Stanford Develop Blood Test to Predict Immunotherapy Response
The liquid biopsy uses cell-free DNA to map tumor microenvironments, helping identify which patients may benefit from immunotherapy across multiple cancer types
|2 min read
FDA Launches Initiative to Advance Drug Repurposing for Unmet Medical Needs
The agency is particularly focused on new uses to treat chronic or rare diseases, substance use disorders
|2 min read
Roche to Acquire PathAI in a Move to Solve the Digital Pathology Integration Puzzle
By absorbing PathAI’s AISight platform, Roche aims to eliminate vendor fatigue for clinical labs and high capital hurdles that have slowed clinical adoption of AI-powered diagnostics
|2 min read
Vanderbilt Researchers Leverage Liquid Biopsies to Predict Immunotherapy Response in High-Risk Breast Cancer Patients
New study utilizes RNA sequencing of peripheral blood to monitor T-cell activity, offering a potential alternative to invasive tissue biopsies for clinical laboratories and oncologists
|2 min read
Blood-Based RNA Biomarkers Identified for Inflammatory Breast Cancer in Liquid Biopsy Study
Researchers identify RNA-based blood biomarkers for inflammatory breast cancer using TGIRT sequencing, suggesting a potential noninvasive tool for diagnosis and disease monitoring
|5+ min read
Broad-Range PCR and Sequencing Remains a Key Tool for Clinical Laboratories
In an era of emerging tech, broad-range PCR followed by sequencing remains a vital targeted approach for microbial identification
|2 min read
Mass General Brigham Validates Polygenic Risk Score Tool for Predicting 8 Cardiovascular Conditions
New integrated polygenic risk score test, now available across the US, may help identify patients at elevated inherited risk for cardiovascular disease before traditional clinical factors emerge
|2 min read
Clinical Lab Leaders Exit 31st Executive War College with Actionable AI and Operational Blueprints
As the 2026 Executive War College wraps up, industry experts highlight how AI and digital workflows are moving beyond theory to solve critical labor shortages and enhance diagnostic precision
|3 min read
AI Is Entering the Lab. Are Lab Managers Ready?
The lab is adopting AI faster than it can be validated. To get it right, managers must apply the same scrutiny they would to any other tool
|2 min read
FDA Announces Major Steps to Implement Real-Time Clinical Trials
Agency unveils real-time trial proofs-of-concept and upcoming pilot program
|3 min read
